Birdwatch Note
2023-07-30 07:20:54 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Näyttöä ivermektiinin hyödystä Covid-19 lääkkeenä ei ole: "A Cochrane meta-analysis of 11 eligible trials ... [And] additional 3 large randomized clinical trials... [And] Naggie and colleagues again conclude that ivermectin is NOT BENEFICIAL for the treatment of COVID-19." https://jamanetwork.com/journals/jama/fullarticle/2801828
Written by 458BDF63866046733826BE883AA5B29FC5557B108EDDCC75908195706E0B0581
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1685536503554883584
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1685551022553411584
- noteId - 1685551022553411584
- participantId -
- noteAuthorParticipantId - 458BDF63866046733826BE883AA5B29FC5557B108EDDCC75908195706E0B0581 Participant Details
- createdAtMillis - 1690701654457
- tweetId - 1685536503554883584
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Näyttöä ivermektiinin hyödystä Covid-19 lääkkeenä ei ole: "A Cochrane meta-analysis of 11 eligible trials ... [And] additional 3 large randomized clinical trials... [And] Naggie and colleagues again conclude that ivermectin is NOT BENEFICIAL for the treatment of COVID-19." https://jamanetwork.com/journals/jama/fullarticle/2801828
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-07-30 07:20:54 UTC (1690701654457) |
1969-12-31 23:59:59 UTC (-1) |
2023-07-31 02:12:18 UTC (1690769538949) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-07-30 15:22:49 -0500 | Rating Details | |
| 2023-07-30 15:11:26 -0500 | Rating Details | |
| 2023-07-30 13:20:59 -0500 | Rating Details | |
| 2023-07-30 12:48:14 -0500 | Rating Details | |
| 2023-07-30 12:45:38 -0500 | Rating Details | |
| 2023-07-30 10:27:37 -0500 | Rating Details | |
| 2023-07-30 10:10:36 -0500 | Rating Details | |
| 2023-07-30 09:57:39 -0500 | Rating Details | |
| 2023-07-30 08:11:56 -0500 | Rating Details | |
| 2023-07-30 05:05:39 -0500 | Rating Details | |
| 2023-07-30 05:02:40 -0500 | Rating Details | |
| 2023-07-30 04:59:19 -0500 | Rating Details | |
| 2023-07-30 04:37:02 -0500 | Rating Details | |
| 2023-07-30 04:24:24 -0500 | Rating Details | |
| 2023-07-30 03:40:24 -0500 | Rating Details | |
| 2023-07-30 02:34:41 -0500 | Rating Details | |
| 2023-07-30 02:31:21 -0500 | Rating Details | |
| 2023-07-30 02:29:28 -0500 | Rating Details | |
| 2023-07-30 02:26:59 -0500 | Rating Details | |
| 2023-07-30 23:03:55 -0500 | Rating Details |